RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AKRO
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Wednesday for Akero Therapeutics Inc.
(Updated on May 01, 2024)

Sell candidate since Apr 19, 2024 Loss -3.28% PDF

The Akero Therapeutics Inc. stock price gained 0.96% on the last trading day (Wednesday, 1st May 2024), rising from $19.89 to $20.08. During the last trading day the stock fluctuated 4.67% from a day low at $19.72 to a day high of $20.64. The price has risen in 6 of the last 10 days but is still down by -7.04% for this period. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 368 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $20.57 million.

The stock lies in the lower of a very wide and falling trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $18.79 is broken, it will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -6.49% during the next 3 months and, with a 90% probability hold a price between $17.57 and $27.98 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AKRO Signals & Forecast

A buy signal was issued from a pivot bottom point on Thursday, April 25, 2024, and so far it has risen 6.08%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Akero Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $23.04. On a fall, the stock will find some support from the short-term average at $19.93. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal.

Support, Risk & Stop-loss for Akero Therapeutics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $18.60 and $17.89. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Akero Therapeutics Inc. finds support just below today's level at $18.60. If this is broken, then the next support from accumulated volume will be at $17.89 and $17.76.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.92 between high and low, or 4.67%. For the last week, the stock has had daily average volatility of 5.73%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (AKRO) For The Upcoming Trading Day Of Thursday 2nd

For the upcoming trading day on Thursday, 2nd we expect Akero Therapeutics Inc. to open at $20.15, and during the day (based on 14 day Average True Range), to move between $18.87 and $21.29, which gives a possible trading interval of +/-$1.21 (+/-6.02%) up or down from last closing price. If Akero Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 12.04% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $20.59 (2.54%) than the support at $18.60 (7.37%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Akero Therapeutics Inc. stock A Buy?

Akero Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -1.191 Sell Candidate Unchanged

Predicted Opening Price for Akero Therapeutics Inc. of Thursday, May 2, 2024

Fair opening price May 2, 2024 Current price
$20.15 ( 0.332%) $20.08

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AKRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.07 4.91 %
R2 20.72 3.16 %
R1 20.50 2.08 %
Current price: 20.08
Support S1 19.80 -1.42 %
S2 19.58 -2.50 %
S3 19.23 -4.25 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 21.88 8.96 %
R2 21.75 8.32 %
R1 20.59 2.54 %
Current price 20.08
Support S1 18.60 -7.37%
S2 17.89 -10.91%
S3 17.76 -11.55%

FAQ

What is the symbol for Akero Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Akero Therapeutics Inc. is AKRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

How to buy Akero Therapeutics Inc. Stock?
Akero Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Akero Therapeutics Inc. Stock.

What's the current price of Akero Therapeutics Inc. Stock?
As of the end of day on the May 01, 2024, the price of an Akero Therapeutics Inc. (AKRO) share was $20.08.

What is the 52-week high and low for Akero Therapeutics Inc. Stock?
The 52-week high for Akero Therapeutics Inc. Stock is $58.38 and the 52-week low is $11.25.

What is the market capitalization of Akero Therapeutics Inc. Stock?
As of the May 01, 2024, the market capitalization of Akero Therapeutics Inc. is 1.353B.

When is the next earnings date for Akero Therapeutics Inc.?
The upcoming earnings date for Akero Therapeutics Inc. is May 20, 2024.
Click to get the best stock tips daily for free!

About Akero Therapeutics Inc.

Akero Therapeutics. Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regulates metabolism of lipids, carbohydrates, and proteins throughout the body. It also conducts a Phase 2a ... AKRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT